Consequently, there is an ongoing need for the identification of novel therapeutic agents to effectively treat or prevent HER2‐positive breast cancer, with particular interest in those derived from medicinal plants as a promising alternative approach. This evidence concerns the gene ERBB2 and breast carcinoma.